Study reveals potential new strategy for managing inflammatory bowel disease
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Related Posts
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) has announced that it has added Pfizer’s maternal respiratory syncytial […]
Migraine takes the spotlight at European Parliament
EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in […]
PharmaTimes MSEA and NIEA awards are open for entry
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024 PharmaTimes is excited […]